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Edited by Lukas HuberAbstract b-Catenin/Tcf and NF-jB pathways play an impor-
tant role in biological functions. We determined the underlying
mechanisms of diﬀerential interaction between two pathways in
various human cancer cell lines. NF-jB positively regulated
b-catenin/Tcf pathways in human glioblastoma, whereas it has
an opposite eﬀect on b-catenin/Tcf pathways in colon, liver,
and breast cancer cells. Expression of lucine zipper tumor sup-
pressor 2 (lzts2) was positively regulated by NF-jB activity in
colon, liver, and breast cancer cells, whereas negatively regulated
in glioma cells. Downregulation of lzts2 increased the b-catenin/
Tcf promoter activity and inhibited NF-jB-induced modulation
of the nuclear translocation of b-catenin. These data indicate
that the diﬀerential crosstalk between b-catenin/Tcf and NF-jB
pathway in various cancer cells is resulted from the diﬀerences in
the regulation of NF-jB-induced lzts2 expression.
 2008 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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tumor suppressor 21. Introduction
The Wnt family of secretory glycoproteins plays an impor-
tant role in embryonic development, the induction of cell
polarity, and in the determination of cell fate. Deregulation
of Wnt signaling disrupts axis formation in embryos [1–3]
and is associated with multiple human malignancies [4]. Wnt
signaling also plays an important role in the proliferation
and diﬀerentiation of stem cells including human mesenchymal
stem cells (hMSCs) [5,6]. The NF-jB signaling pathway is an-
other important signal transduction pathway that plays a crit-
ical role in activating the expression of genes involved in the
immune and inﬂammatory response and in regulating cellular*Corresponding author. Address: Department of Physiology, School
of Medicine, Pusan National University, 1 Ga, Ami-Dong, Suh-Gu,
Pusan 602-739, Republic of Korea. Fax: +82 51 246 6001.
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doi:10.1016/j.febslet.2008.01.029apoptosis [7–10]. NF-jB is an important mediator for the pro-
duction of cytokine and chemokines in hMSCs [11].
Deng and colleagues [12] ﬁrst suggested that b-catenin inter-
acted with and inhibited NF-jB in human colon and breast
cancer cells. They found that b-catenin could physically com-
plex with NF-jB, resulting in a reduction of NF-jB DNA
binding, transactivation activity, and target gene expression
[12]. Subsequently, several studies have demonstrated that
the activation of the b-catenin/Tcf pathway negatively regu-
lates the NF-jB pathway in colon and breast cancer cells
[12,13] and in response to bacterial stimulation in intestinal
epithelial cells [14]. On the other hand, stimulation of the
Wnt cascade through the upregulation of either Wnt or degra-
dation-resistant b-catenin signiﬁcantly enhances both baseline
and TNF-a-induced NF-jB activity, which is mediated
through the E3 ligase TrCP1, in vascular smooth muscles [15].
A recent study showed that lzts2 (lucine zipper tumor sup-
pressor 2), a putative tumor suppressor [16], interacts with b-
catenin, represses the transactivation of b-catenin, and aﬀects
the subcellular localization of b-catenin. We found that the
activity of NF-jB regulated the expression of lzts2 in human
adipose tissue-derived mesenchymal stem cells [17]. These ﬁnd-
ings highlight the complex interactions between the b-catenin/
Tcf and NF-jB signaling pathways and further emphasize the
importance of characterizing their interactive role in biological
functions. In this study, we determined crosstalk between b-
catenin/Tcf and NF-jB pathways in various human cancer
cells.2. Materials and methods
2.1. Cell culture
All cancer cell lines (human glioma cell line, U87MG and GBM-05;
human colon cancer cell line, COLO201 and KM12C; and breast can-
cer cell line, SKBR3; human hepatocellular liver carcinoma cell line,
HepG2 and Hep3B) were grown in the speciﬁed media (Dulbeccos
modiﬁed Eagles media containing 10% fetal bovine serum).
2.2. Reporter gene assay
All transient transfections were performed with Lipofectamine Plus
Reagent (Invitrogen). The transient transfections were performed
using pTOP-ﬂash, pFOP-ﬂash, pNF-jB-Luc, pCMV-b-Gal plasmid
(Clontech Laboratories Inc., CA) and the p65 plasmid (pCMVp65
NF-jB). Reporter gene assay done as described [18].blished by Elsevier B.V. All rights reserved.
H.H. Cho et al. / FEBS Letters 582 (2008) 616–622 6172.3. Nuclear and cytosolic fractionation and Western blot analysis
The cells were separated into cytoplasmic and nuclear fractions as
described [19]. Monoclonal antibodies (b-catenin and b-actin; BD Bio-
sciences Clontech, CA, NF-jBp65, Santa Cruz Biotechnology Inc.,
CA) were used for immunoblotting.
2.4. Decoy oligodeoxynucleotide (ODN) technique
The NF-jB decoy technique was performed as described previously
[20].
2.5. Small interfering RNA (siRNA) transfection
siRNA duplex oligo (on-TARGET plus SMART pool, Dharmacon
Inc., CO) targeting lzts2 (leucine zipper, putative tumor suppressor 2)
mRNA or non-targeting duplex oligo (on-TARGET plus siCON-
TROL, Dharmacon Inc., CO) as a negative control were transfected
using DharmaFECT Transfection Reagent.
2.6. Reverse transcription-polymerase chain reaction (RT-PCR)
analysis
The total cellular RNA was isolated from the cells and reverse tran-
scribed using the conventional protocols. The cDNAs were ampliﬁed
by PCR with 30 cycles at 94 C for 30 s, 60 C for 30 s, and 72 C
for 30 s. PCR ampliﬁcation was performed using the following primer
sets: GAPDH 5 0-TCCATGACAACTTTGGTATCG-3 0, 5 0-TGTA-
GCCAAATTCGTTGTCA-3 0, lzts2, 5 0-CTGTGTCCTGGAAGG-
AAAGC-3 0, 5 0-CTCCCACTTGGTCTCCTCAA-30. The designed
primers were used to amplify the PCR, and GAPDH was used as a
control.
2.7. RT-PCR
The primer sequences used in the experiment were as follows:
b-actin, 5 0-CTGGTGCCT GGG GCG-3 0, 5 0-AGCCTCGCCT-
TTGCCGA-3 0; lzts2, 5 0-AGAAGCGGCAATTGCAGGAC-3 0, 5 0-A
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Fig. 1. Eﬀect of NF-jB inhibitors on NF-jB and b-catenin/Tcf signaling path
constructs and b-Gal vector. (B) Cells were cotransfected with either TOPFLA
cells were treated without or with SN50 (50 and 100 lg/ml) for 48 h. Lucifer
means ± S.E.M. of four diﬀerent experiments. *P < 0.05 compared with dataCTCGCCTGATTTCTGGCACA-3 0. Real-time quantitation done as
described [21].
2.8. Statistical analysis
Comparisons between two groups were analyzed via a Students
t-test. (P < 0.05), and comparisons between three groups were ana-
lyzed by ANOVA with a Student–Newman–Keuls post hoc test
(P < 0.05). Data are presented as means ± S.E.3. Results
We determined the eﬀect of inhibition of NF-jB signaling by
treatment with SN50, an inhibitor of NF-jB nuclear transloca-
tion on b-catenin/Tcf signaling. In this experiment, we used
two colon cancer cells (COLO-201 and KM12C), two glioma
cells (U87MG and GBM-05 [22]), two hepatoma cells (HepG2
and Hep3B), and one breast cancer cells (SKBR3). The treat-
ment with SN50 (50 or 100 lg/ml) inhibited the luciferase
activity of the NF-jB promoter-luciferase construct in all of
cells to be tested in the experiment (Fig. 1A). The treatment
of SN50 inhibited the luciferase activity of the Top-Flash con-
struct in glioma cell lines, U87MG and GBM-05, without
aﬀecting that of the Fop-Flash construct (Fig. 1B). In contrast,
the treatment of SN50 (50 or 100 lg/ml) increased Tcf pro-
moter activity in the COLO-201, KM12C, SKBR3, HepG2,
and Hep3B cell lines (Fig. 1B).
To conﬁrm the diﬀerential crosstalk between the NF-jB and
b-catenin/Tcf signaling pathways in cancer cell lines, we trea-Cont 
SN50 
SN50 
GBM-05 KM12C
(50μg/ml)
(100μg/ml)
*
*
*
*
+   +  +  - - - +  +  +  - - - +  +  +   - - - +  +  +  - - -
     - - - +  +  +     - - - +  +  +     - - - +   +  +      - - - +  +  +
- - - - - - - -
HepG2 Hep3B GBM-05 KM12C
*
*
*
*
*
*
*
*
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SH or FOPFLASH reporter constructs and b-Gal vector. Transfected
ase activity was normalized by b-galactosidase activity. Data represent
in the absence of SN50.
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and GBM-05 cancer cells with mutant and NF-jB decoy.
The treatment with NF-jB decoy decreased the luciferase
activity of NF-jB in comparison to treatment with the mutant
decoy in all cancer cell lines (Fig. 2A). In Tcf promoter activ-
ity, treatment with NF-jB decoy increased activity of Tcf pro-
moter in colon, hepatic, and breast cancer cells in contrast with
glioma cells in which the treatment of NF-jB decoy decreased
Tcf promoter activity (Fig. 2B). The overexpression of p65 by
plasmid transfection increased the luciferase activity of both
the Tcf and NF-jB promoters in U87MG and GBM-05, but
decreased Tcf promoter activity in COLO-201, KM12C,
HepG2, Hep3B, and SKBR cells (Fig. 2A and B).
To understand the mechanisms underlying the crosstalk be-
tween the NF-jB and b-catenin/Tcf signaling pathways in can-
cer cells, the b-catenin levels in the total, nuclear, and cytosolic
fractions were determined by Western blot analysis. The SN50
treatment inhibited the nuclear translocation of p65 in COLO-
201, SKBR3, and U87MG cells. Although SN50 (100 lg/ml)
treatment did not aﬀect the total b-catenin levels, it increasedA
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Fig. 2. Eﬀect of NF-jB activity on b-catenin/Tcf pathway in cancer cells. (A
constructs vector in combination with b-Gal vector, and incubated with eit
overexpression, cells were cotransfected with either pCMV65 or pCMV empty
determined at 48 h after transfection and normalized by b-galactosidase ac
*P < 0.05 compared with the data of mutant decoy or pCMV vector-transfect
and b-catenin in cancer cells. Cells was treated without or with SN50 (10
immunoblotted with antibodies against b-catenin, p65 and b-actin. One reprthe b-catenin levels in the cytosolic fractions and decreased
the b-catenin levels in the nuclear fractions of U87MG, indi-
cating that SN50 inhibited nuclear translocation of b-catenin
as well as NF-jB (Fig. 2C). In contrast, SN50 increased nucle-
ar translocation of b-catenin in COLO-201 and SKBR3.
A recent study showed that lzts2 is involved in the nuclear
translocation of b-catenin [16]. Therefore, we determined
whether diﬀerential regulation of lzts2 expression by NF-jB
according to cell types is responsible for opposite responses
of b-catenin/Tcf pathway by NF-jB activity. RT-PCR and
real-time PCR analysis showed that SN50 (100 lg/ml) and
NF-jB decoy increased lzts2 expression in U87MG and de-
creased it in COLO-201, SKBR3, HepG2, Hep3B, and
KM12C cells. In contrast, p65 overexpression by plasmid
transfection decreased lzts2 expression in U87MG and in-
creased it in COLO-201, SKBR3, HepG2, Hep3B, and
KM12C cells (Fig. 3A and B). To further conﬁrm the role of
lzts2 on the interaction between b-catenin/Tcf and NF-jB
pathways, siRNA duplex oligonucleotides were transfected
for the downregulation of lzts2 expression. lzts2 siRNA-trans-ecoy
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Fig. 3. Eﬀect of NF-jB signal on lzts2 expression in cancer cells. (A) Cells was transfected with pCMV and pCMV65 plasmid or treated with mutant
decoy, NF-jB decoy and SN50 (100 lg/ml). Total RNAs were isolated at 48 h after transfection or treatment, and lzts2 mRNA level in cancer cells
was determined by RT-PCR (A) and real-time PCR (B). Data represent means ± S.E.M. of three diﬀerent experiments. *P < 0.05 compared with the
data of control cells.
H.H. Cho et al. / FEBS Letters 582 (2008) 616–622 619fected cells showed signiﬁcant downregulation of the lzts2 gene
in the cancer cells (by 70–80%) (Fig. 4A and B). We then deter-
mined Tcf and NF-jB promoter activity in lzts2 siRNA-trans-
fected cells. The downregulation of lzts2 increased Tcf
promoter activity in COLO-201, SKBR3, U87MG, HepG2,
Hep3B, and KM12C cells (Fig. 4C). The transfection of lzts2
siRNA increased NF-jB promoter activity in U87MG,
whereas it inhibited NF-jB promoter activity in COLO-201,
SKBR3 HepG2, Hep3B, and KM12C cells (Fig. 4D). To con-
ﬁrm these ﬁndings, Western blot analysis was used to deter-
mine the levels of b-catenin in the cancer cell lines. The
downregulation of lzts2 expression increased the total and nu-
clear b-catenin levels, but decreased the cytosolic b-catenin lev-
els in the cancer cells (Fig. 4E).
To further determine the role of lzts2 on b-catenin/Tcf path-
way, we measured the eﬀect of lzts2 downregulation on nuclear
translocation of b-catenin. In COLO-201, SKBR3, and
HepG2 cells, the treatment of SN50 (100 lg/ml) increased nu-
clear translocation of b-catenin, but the overexpression of p65decreased it. In U87MG and GBM-05 cells, the treatment of
SN50 decreased nuclear translocation of b-catenin, but the
overexpression of p65 increased it. In lzts2 downregulated
cells, the alterations of the ratio of nuclear/cytosolic b-catenin
levels induced by p65 overexpression or SN50 treatment were
signiﬁcantly decreased (Fig. 4F).4. Discussion
b-Catenin inhibited the activity of NF-jB in colon and
breast cancer cells [12], but induced the activation of NF-jB
in vascular smooth muscle cells [15] and human embryonic
kidney cells [23]. Studies concerning the crosstalk between
NF-jB and the b-catenin/TCf pathways have revealed that
the interaction between the two pathways occurs at multiple
cellular levels. The data from studies in colon and breast can-
cer cell lines showed that b-catenin is able to bind to NF-jB
and reduce the amount of NF-jB DNA binding [12]. The
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H.H. Cho et al. / FEBS Letters 582 (2008) 616–622 621activity of NF-jB was enhanced by glycogen synthase kinase-
3b (GSK-3b), which contributes to the degradation of b-cate-
nin and represses the b-catenin/Tcf signaling pathway [4,24].
The transactivation of Tcf/Lef has been known to lead to the
upregulation of the E3 ligase b-TrCP1 [15]. b-TrCP1 binds
identical phosphorylated motifs on b-catenin and IjB, result-
ing in the tethering of the ubiquitin ligase machinery and sub-
sequent degradation of IjB by the 26S proteasome [23,25,26],
which can provide an explanation for the b-catenin-induced
activation of NF-jB. However, these studies were focused on
the b-catenin-mediated modulation of NF-jB, and the NF-
jB-mediated modulation of the b-catenin/Tcf signaling path-
ways has not been studied well.
The results of our study showed that the modulation of the
NF-jB signaling pathway diﬀerentially aﬀects the b-catenin/
Tcf signaling pathways according to the type of cancer cells.
The modulation of NF-jB by the inhibition of NF-jB nuclear
translocation, decoy oligonucleotides, and the overexpression
of NF-jB directly aﬀects the b-catenin/Tcf pathway in glioma
cells, but inversely aﬀects this pathway in colon, hepatic, and
breast cancer cells. The mechanisms mentioned above do not
provide a suﬃcient explanation for the NF-jB-induced modu-
lation of b-catenin/Tcf pathways.
A recent study showed that lzts2 [16] interacts with b-cate-
nin, represses the transactivation of b-catenin, and aﬀects the
subcellular localization of b-catenin. In this study, we demon-
strated that NF-jB increased the expression of lzts2 in colon,
breast, and hepatic cancer cells, but inhibited lzts2 expression
in glioma cancer cells. These ﬁndings provide a good explana-
tion for the diﬀerential eﬀects of NF-jB activity on the b-cate-
nin/Tcf pathways. That is, the increased nuclear translocation
of b-catenin in colon, hepatic, and breast cancer cells by SN50
could be explained by a concomitant decrease in lzts2 expres-
sion. Conversely, the decreased nuclear translocation of b-
catenin by SN50 in glioma cells could be related to the increase
in lzts2 expression. The ﬁndings that the downregulation of
lzts2 by RNA interference upregulated the levels of b-catenin,
increased the translocation of b-catenin into the nucleus, in-
creased the activity of the Tcf promoter, diﬀerentially regu-
lated the activity of NF-jB according to cancer cell types
and inhibited NF-jB-induced modulation of b-catenin translo-
cation provide further support that lzts2 plays a central role in
the interaction between the NF-jB and b-catenin/Tcf path-Wnt stimuli
GSK3 IKK
β-catenin IκB
Tcf-dependent
transcription
NF-κB
transcription
lzts2
Tcf target(s)
Glioma
Colon, Liver and Breast cancer
Fig. 5. lzts2 mediates crosstalk between NF-jB and b-catenin/Tcf
pathways in cancer cells.ways. A schematic diagram in Fig. 5 illustrates our current
understanding of the reciprocal interaction between the Wnt
and NF-jB signaling pathways in cancer cells. Activation of
NF-jB decreases lzts2 expression in colon, but increases it
in. The changes in lzts2 level result in diﬀerential modulation
of nuclear translocation of b-catenin and transactivation of
Tcf/Lef.
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